Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 58.56
+0.23 (0.39%)
Apr 29, 2026, 3:00 PM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 6.4 billion as of April 29, 2026. Its market cap has increased by 25.14% in one year.
Market Cap
6.40B
Enterprise Value
6.60B
Revenue
1.19B
Ranking
n/a
PE Ratio
33.31
Stock Price
58.56
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 6.40B, a decrease of -33.39%. That is a compound annual growth rate of -8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.37B | -6.15% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
| Jun 21, 2021 | 9.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guizhou Bailing Group Pharmaceutical | 6.78B |
| Tianjin Tianyao Pharmaceuticals | 6.75B |
| Hainan Haiyao | 6.67B |
| Shandong Wit Dyne Health | 6.64B |
| Tibet Duo Rui Pharmaceutical | 6.37B |
| Hunan Jiudian Pharmaceutical | 6.34B |
| Heilongjiang ZBD Pharmaceutical | 6.23B |
| ChengDa Pharmaceuticals | 6.10B |